phrykt

Royalty Pharma (RPRX) cash: $619M

Royalty Pharma held $619M in cash and cash equivalents on Dec 31, 2025, down 33.4% from $929M a year earlier.

From Royalty Pharma's filings with the SEC · Read the filing · RPRX stock page

Royalty Pharma cash by year

$1.5B2021$1.7B2022$477M2023$929M2024$619M2025

#766 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$619M-33%
Dec 31, 2024$929M+95%
Dec 31, 2023$477M-72%
Dec 31, 2022$1.7B+11%
Dec 31, 2021$1.5B–

Cash of similar companies

Companies in the same industry as Royalty Pharma, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Zai Lab$680MDec 31, 2025
Immunome$653MDec 31, 2025
Royalty Pharma$619MDec 31, 2025
Wave Life Sciences$602MDec 31, 2025
Organon$574MDec 31, 2025
BridgeBio Pharma$570MDec 31, 2025
Innoviva$551MDec 31, 2025

Questions and answers

What is Royalty Pharma's cash?

Royalty Pharma held $619M in cash and cash equivalents on Dec 31, 2025, down 33.4% from $929M a year earlier.

Numbers as reported in Royalty Pharma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology